Haddaji, N.; Bahloul, B.; Bahia, W.; Bechambi, O.; Mahdhi, A.
Development of Nanotechnology-Based Drug Delivery Systems for Controlling Clinical Multidrug-Resistant Staphylococcus aureus and Escherichia coli Associated with Aerobic Vaginitis. Pharmaceutics 2023, 15, 2133.
https://doi.org/10.3390/pharmaceutics15082133
AMA Style
Haddaji N, Bahloul B, Bahia W, Bechambi O, Mahdhi A.
Development of Nanotechnology-Based Drug Delivery Systems for Controlling Clinical Multidrug-Resistant Staphylococcus aureus and Escherichia coli Associated with Aerobic Vaginitis. Pharmaceutics. 2023; 15(8):2133.
https://doi.org/10.3390/pharmaceutics15082133
Chicago/Turabian Style
Haddaji, Najla, Badr Bahloul, Wael Bahia, Olfa Bechambi, and Abdelkarim Mahdhi.
2023. "Development of Nanotechnology-Based Drug Delivery Systems for Controlling Clinical Multidrug-Resistant Staphylococcus aureus and Escherichia coli Associated with Aerobic Vaginitis" Pharmaceutics 15, no. 8: 2133.
https://doi.org/10.3390/pharmaceutics15082133
APA Style
Haddaji, N., Bahloul, B., Bahia, W., Bechambi, O., & Mahdhi, A.
(2023). Development of Nanotechnology-Based Drug Delivery Systems for Controlling Clinical Multidrug-Resistant Staphylococcus aureus and Escherichia coli Associated with Aerobic Vaginitis. Pharmaceutics, 15(8), 2133.
https://doi.org/10.3390/pharmaceutics15082133